Literature DB >> 25559953

Hypoxia-inducible factor 1 and breast cancer metastasis.

Zhao-Ji Liu1, Gregg L Semenza, Hua-Feng Zhang.   

Abstract

Accumulating evidence has shown that the hypoxic microenvironment, which is critical during cancer development, plays a key role in regulating breast cancer progression and metastasis. The effects of hypoxia-inducible factor 1 (HIF-1), a master regulator of the hypoxic response, have been extensively studied during these processes. In this review, we focus on the roles of HIF-1 in regulating breast cancer cell metastasis, specifically its effects on multiple key steps of metastasis, such as epithelial-mesenchymal transition (EMT), invasion, extravasation, and metastatic niche formation. We also discuss the roles of HIF-1-regulated non-coding RNAs in breast cancer metastasis, and therapeutic opportunities for breast cancer through targeting the HIF-1 pathway.

Entities:  

Keywords:  Breast cancer; Hypoxia-inducible factor 1 (HIF-1); Metastasis

Mesh:

Substances:

Year:  2015        PMID: 25559953      PMCID: PMC4288942          DOI: 10.1631/jzus.B1400221

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  104 in total

Review 1.  Epithelial-mesenchymal transitions in tumour progression.

Authors:  Jean Paul Thiery
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

2.  Tumor hypoxia and malignant progression.

Authors:  Peter Vaupel; Arnulf Mayer; Michael Höckel
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

3.  Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line.

Authors:  Xin Hua Liu; Alexander Kirschenbaum; Min Lu; Shen Yao; Amy Dosoretz; James F Holland; Alice C Levine
Journal:  J Biol Chem       Date:  2002-10-24       Impact factor: 5.157

4.  Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch.

Authors:  David Lando; Daniel J Peet; Dean A Whelan; Jeffrey J Gorman; Murray L Whitelaw
Journal:  Science       Date:  2002-02-01       Impact factor: 47.728

5.  Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.

Authors:  Reinhard Bos; Petra van der Groep; Astrid E Greijer; Avi Shvarts; Sybren Meijer; Herbert M Pinedo; Gregg L Semenza; Paul J van Diest; Elsken van der Wall
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

6.  An open randomised trial of second-line endocrine therapy in advanced breast cancer. comparison of the aromatase inhibitors letrozole and anastrozole.

Authors:  C Rose; O Vtoraya; A Pluzanska; N Davidson; M Gershanovich; R Thomas; S Johnson; J J Caicedo; H Gervasio; G Manikhas; F Ben Ayed; S Burdette-Radoux; H A Chaudri-Ross; R Lang
Journal:  Eur J Cancer       Date:  2003-11       Impact factor: 9.162

7.  Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells.

Authors:  Ryo Fukuda; Kiichi Hirota; Fan Fan; Young Do Jung; Lee M Ellis; Gregg L Semenza
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

8.  Leukocyte angiotensin II levels inpatients with essential hypertension:relation to insulin resistance.

Authors:  Noboru Fukuda; Mari Nakayama; Teng Jian; Chikara Satoh; Tomohiro Nakayama; Masayoshi Soma; Yoichi Izumi; Katsuo Kanmatsuse
Journal:  Am J Hypertens       Date:  2003-02       Impact factor: 2.689

9.  Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling.

Authors:  Kenji Kasuno; Satoshi Takabuchi; Kazuhiko Fukuda; Shinae Kizaka-Kondoh; Junji Yodoi; Takehiko Adachi; Gregg L Semenza; Kiichi Hirota
Journal:  J Biol Chem       Date:  2003-11-04       Impact factor: 5.157

Review 10.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

View more
  75 in total

Review 1.  Mitochondrial ROS control of cancer.

Authors:  María Del Pilar Sosa Idelchik; Ulrike Begley; Thomas J Begley; J Andrés Melendez
Journal:  Semin Cancer Biol       Date:  2017-04-23       Impact factor: 15.707

2.  Ursolic acid sensitized colon cancer cells to chemotherapy under hypoxia by inhibiting MDR1 through HIF-1α.

Authors:  Jian-Zhen Shan; Yan-Yan Xuan; Qi Zhang; Jian-Jin Huang
Journal:  J Zhejiang Univ Sci B       Date:  2016-09       Impact factor: 3.066

3.  Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.

Authors:  Javier F Torres-Roca; William J Fulp; Jimmy J Caudell; Nicolas Servant; Marc A Bollet; Marc van de Vijver; Arash O Naghavi; Eleanor E Harris; Steven A Eschrich
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-06-25       Impact factor: 7.038

4.  Three dimensional engineered models to study hypoxia biology in breast cancer.

Authors:  Vaishali Aggarwal; Oshin Miranda; Paul A Johnston; Shilpa Sant
Journal:  Cancer Lett       Date:  2020-06-20       Impact factor: 8.679

Review 5.  Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia.

Authors:  Devarajan Nalini; Jayaraman Selvaraj; Ganesan Senthil Kumar
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-13       Impact factor: 4.553

6.  Thyroid Hormone Controls Breast Cancer Cell Movement via Integrin αV/β3/SRC/FAK/PI3-Kinases.

Authors:  Marina Inés Flamini; Ivonne Denise Uzair; Gisela Erika Pennacchio; Flavia Judith Neira; Joselina Magali Mondaca; Fernando Dario Cuello-Carrión; Graciela Alma Jahn; Tommaso Simoncini; Angel Matías Sanchez
Journal:  Horm Cancer       Date:  2017-01-03       Impact factor: 3.869

7.  Selective Reversible Inhibition of Autophagy in Hypoxic Breast Cancer Cells Promotes Pulmonary Metastasis.

Authors:  Christopher M Dower; Neema Bhat; Edward W Wang; Hong-Gang Wang
Journal:  Cancer Res       Date:  2016-11-15       Impact factor: 12.701

8.  PML promotes metastasis of triple-negative breast cancer through transcriptional regulation of HIF1A target genes.

Authors:  Manfredi Ponente; Letizia Campanini; Roberto Cuttano; Andrea Piunti; Giacomo A Delledonne; Nadia Coltella; Roberta Valsecchi; Alessandra Villa; Ugo Cavallaro; Linda Pattini; Claudio Doglioni; Rosa Bernardi
Journal:  JCI Insight       Date:  2017-02-23

9.  CoCl2 increases the expression of hypoxic markers HIF-1α, VEGF and CXCR4 in breast cancer MCF-7 cells.

Authors:  Qing Li; Rong Ma; Mei Zhang
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

10.  The Milk Protein Alpha-Casein Suppresses Triple Negative Breast Cancer Stem Cell Activity Via STAT and HIF-1alpha Signalling Pathways in Breast Cancer Cells and Fibroblasts.

Authors:  Kirsten E L Garner; Nathan J Hull; Andrew H Sims; Rebecca Lamb; Robert B Clarke
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-09-12       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.